Enact Holdings Heads Into Earnings With Options Tilting Bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
ACT reports Q2 results on July 31 with options positioning at its most call-heavy in recent memory — a sharp contrast to the cautious hedging that typically precedes a financial sector earnings print.
The options signal is the clearest story heading into Thursday. The put/call ratio has collapsed to 0.065, more than two standard deviations below its 20-day average of 0.11, meaning call buyers are overwhelming put buyers by a wide margin. That degree of one-sided bullish positioning is unusual for a mortgage insurer, and it coincides with a stock that has already gained 5.4% on the week and 6% over the past month, closing at $47.97. The borrow market adds nothing alarming to the picture: availability is abundant at roughly 650% of shares short, cost to borrow is negligible at 0.50%, and short interest has drifted lower over the past month to 2.5% of the free float. There is no meaningful short squeeze dynamic in play.
The analyst consensus tells a more cautious story than the options market does. JP Morgan raised its target modestly to $46 on July 13 while holding its Neutral rating — leaving ACT trading above the Street's mean target of $46. BofA remains the most constructive voice, carrying a Buy rating with a $49 target set in April. RBC initiated coverage in late June at Sector Perform with a $46 target, adding another neutral voice to a consensus that has been gradually ratcheting targets higher without upgrading its conviction. The EV/EBIT factor score ranks in the 81st percentile, suggesting the valuation remains reasonable on an earnings-power basis even after the year-to-date run; the P/E sits near 9.9x, a modest multiple for a company that ranks in the 57th percentile on EPS surprise. EPS momentum scores, however, are weak — ranking in the 13th percentile on the 30-day measure and the 18th on 90-day — which means the forward earnings revision trend has not been supportive of the rally.
One structural feature worth noting is the ownership table. Genworth Financial holds nearly 80% of shares outstanding and has been steadily trimming its stake through monthly block sales — roughly 600,000 shares each in April, May, and June, totalling over $75 million in disposals over the past 90 days. This is a controlled secondary distribution rather than distress selling, but it represents a persistent, predictable supply overhang that the market has so far absorbed comfortably. Peers NMIH and MTG each gained around 1–2% on the week, broadly in line with ACT's move, suggesting the sector rather than company-specific factors has driven the recent strength.
The print on July 31 will test whether the underlying insurance operations — new insurance written, claims experience, and the trajectory of the loss ratio — can justify a stock price that now sits above the consensus analyst target, against a backdrop of call-heavy positioning that has already priced in good news.
Stocks in this article
See the live data behind this article on ORTEX.
Open ACT on ORTEX →How this article was generated
- Generated
- 29 Jul 2026, 04:32
- Data as of
- 29 Jul 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.